Ocugen OCGN
NASDAQ OCGN
$0.96 +0.01 (+1.09%)
At close: Nov 11, 2026 · 4:00 PM EST

Ocugen (OCGN) Share-based Compensation (IS) (2015 - 2023)

Updated

Ocugen's Share-based Compensation (IS) came in at $2.17 million for Q3 2023, down 12.9% from $2.5 million a year earlier.

Analysis

Ocugen (OCGN) Share-based Compensation (IS) (2015 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Ocugen 322.34 Mn 87.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 2.17 Mn
Sep 30, 2022 2.50 Mn
Jun 30, 2016 336,000.00
Mar 31, 2016 311,000.00
Jun 30, 2015 257,000.00
Mar 31, 2015 235,000.00
API Access

Ocugen Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=OCGN&period=max&api_key=YOUR_API_KEY